Slide 1
Slide 1
Slide 1

Wegovy® Pill

FDA Approved

Details

Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection.

Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection.

Wegovy® stands out as a clinically proven option for individuals seeking structured, long-term weight management under medical supervision. Key advantages include:

FDA-approved for chronic weight management
Specifically indicated for adults with obesity or overweight plus weight related health factors.

Targets appetite regulation at the hormonal level as a GLP-1 receptor agonist
Wegovy helps reduce hunger, cravings, and overeating by reinforcing natural satiety signals.

Clinically meaningful results
Studies show average weight loss of 15% or more when used consistently alongside nutrition and lifestyle changes.

Once a day convenience
Simple, at-home pill fit easily into real-life routines without frequent clinic visits.

Provider-guided care
Treatment includes personalized dosing, gradual titration, and ongoing clinical oversight to optimize results and manage side effects.

Designed for sustainability
Wegovy supports consistency, adherence, and metabolic alignment-critical factors for maintaining progress beyond short-term weight loss.

Through Naked Rx, Wegovy is delivered as part of a medically guided program focused on safety, personalization, and long-term success.

Wegovy Consultation

Premium Care
Without Compromise

Personalized Wellness

Custom treatment plans designed around your body, goals, and lifestyle.

Expert-Led Care

Dedicated support from licensed providers committed to your success.

Convenient Access

Premium healthcare and prescriptions delivered without the waiting room.

Long-Term Results

Ongoing monitoring and treatment optimization to help you achieve lasting outcomes.

Not just a shot
A system.

- %

Body fat reduced

- 0 lbs

Avg. weight lost (18 mo.)

- 0 %

Craving reduction

Feature Wegovy® (Semaglutide) Wegovy® (Semaglutide)
Most Prescribed Zepbound® (Tirzepatide) Zepbound® (Tirzepatide)
Drug class GLP-1 agonist GIP + GLP-1 dual agonist
Avg. weight loss ~15% body weight ~20–22.5% body weight
Dosing schedule One daily pill Once weekly
Max dose Up to ~25 mg daily (higher due to digestion) 15 mg
FDA approval year 2023 2023
Cardiovascular benefit
Insurance coverage Broader coverage Growing coverage
Prescription Medication (Paid Only if Approved) From $149/mo From $149/mo

Switch to Naked Rx

Bare numbers. Clear signal.

Six calculators that tell you the truth. BMI. TDEE. Protein. Carbs. Calorie deficit. Daily water. Numbers are not a verdict—they are a starting point.

Updated from your entries

BMI range may warrant provider review

29.0

Your number is not the answer. It is the starting line. A licensed provider reviews everything before treatment is recommended.

Start the assessment

Uncomplicated care,
in your hands.

Six calculators. Six protocols.

One assessment that takes sixty seconds. Built for people
who want healthcare stripped of friction.

Luxury Healthcare
On Your Terms

Complete a quick online assessment, connect with a licensed provider, and receive a customized treatment plan delivered directly to your door.

Choose Your
Treatment

Complete Your
Online Intake

Connect with Our
Licensed Provider

Get Meds Delivered
to Your Door

Frequently Asked Questions

Wegovy® (semaglutide 2.4 mg) is an FDA-approved, once-weekly injectable medication for chronic weight management in adults with a BMI of 30+ or 27+ with at least one weight-related condition.

It works as a GLP-1 receptor agonist — mimicking a natural gut hormone that signals fullness to the brain, slowing digestion and reducing appetite. In clinical trials (STEP program), participants lost an average of ~15% of their body weight over 68 weeks.

GLP-1 also reduces the speed at which food passes through the digestive system. It prolongs digestion, helping to maintain your feeling of fullness for a longer period. Therefore, when you take GLP-1 injections, you feel fuller faster and are less likely to overeat.

One of the key benefits of GLP-1 is its ability to suppress appetite, helping you feel fuller for longer and reducing cravings for unhealthy foods. By curbing your appetite, GLP-1 makes it easier to stick to your dietary goals and maintain a healthy lifestyle.

GLP-1 also plays a crucial role in regulating blood sugar levels. By enhancing insulin sensitivity and reducing glucose production in the liver, GLP-1 helps keep blood sugar levels stable, which is essential for overall health and well-being.

Both Wegovy® and Zepbound® are self-administered as a once-weekly subcutaneous injection — meaning a small needle goes just under the skin, typically in the abdomen, thigh, or upper arm.

Each comes in a pre-filled autoinjector pen that makes dosing simple. Your provider will walk you through the technique, and Kin Meds provides detailed injection instructions with your shipment. Doses are gradually increased over the first several months to minimize side effects.

In the SURMOUNT clinical trials, patients on the highest dose lost an average of ~22.5% of body weight, outperforming Wegovy® in head-to-head data. It’s generally considered the more powerful option but may have different insurance coverage and availability depending on your state.

General FDA eligibility guidelines require:

  • BMI of 30 or higher, OR
  • BMI of 27 or higher plus at least one weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol)

Final eligibility is determined by your licensed provider after reviewing your health intake and lab results. Not all applicants will qualify. Certain medical conditions and medications may be contraindications.

Insurance coverage for branded GLP-1 medications varies significantly by plan. Wegovy® currently has broader insurance coverage than Zepbound®, particularly under plans that cover anti-obesity medications.

Naked Rx operates as a cash-pay program — we provide transparent pricing without relying on insurance approval. However, some patients choose to submit for reimbursement independently through their insurance after receiving their prescription.

The $49 application and screening fee covers the cost of the at-home blood test and clinical intake review — this fee applies regardless of the outcome and is non-refundable as services are rendered during the screening process.

You will not be charged for medication unless a prescription is written and approved. Please review our full Returns & Refund Policy for details.

Naked Rx currently serves patients across most US states. Availability may vary based on state-specific prescribing regulations. During your intake, you’ll be notified if service is not yet available in your state.

Medications are shipped directly to your door in discreet, temperature-controlled packaging by a licensed third-party pharmacy.